Unlocking human potential with breakthrough mammary biotechnology.
BIOMILQ has raised $21.0M in total funding. The most recent round was Series A. The last funding was announced in October 2021.
BIOMILQ's investors include Gaingels, Novo Holdings, Breakthrough Energy Ventures, GGF, Digitalis Ventures.
BIOMILQ is headquartered in Durham, United States.
Unlocking human potential with breakthrough mammary biotechnology.
BIOMILQ is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"BIOMILQ — Funding & Investors." VCBacked, October 20, 2021, https://www.vcbacked.co/company/biomilq. Accessed July 21, 2026.
VCBacked. (2021). BIOMILQ — Funding & Investors. Retrieved July 21, 2026, from https://www.vcbacked.co/company/biomilq
{{cite web |title=BIOMILQ — Funding & Investors |url=https://www.vcbacked.co/company/biomilq |website=VCBacked |access-date=July 21, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated